MXPA05006628A - Tratamiento de insuficiencia cardiaca cronica. - Google Patents
Tratamiento de insuficiencia cardiaca cronica.Info
- Publication number
- MXPA05006628A MXPA05006628A MXPA05006628A MXPA05006628A MXPA05006628A MX PA05006628 A MXPA05006628 A MX PA05006628A MX PA05006628 A MXPA05006628 A MX PA05006628A MX PA05006628 A MXPA05006628 A MX PA05006628A MX PA05006628 A MXPA05006628 A MX PA05006628A
- Authority
- MX
- Mexico
- Prior art keywords
- heart failure
- treatment
- chronic heart
- chf
- heart
- Prior art date
Links
- 206010007558 Cardiac failure chronic Diseases 0.000 title abstract 4
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 229940123769 Xanthine oxidase inhibitor Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 239000003064 xanthine oxidase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/325,420 US20040122067A1 (en) | 2002-12-20 | 2002-12-20 | Treatment of chronic heart failure |
| PCT/US2003/039410 WO2004060489A2 (en) | 2002-12-20 | 2003-12-11 | Treatment of chronic heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05006628A true MXPA05006628A (es) | 2005-09-30 |
Family
ID=32593758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05006628A MXPA05006628A (es) | 2002-12-20 | 2003-12-11 | Tratamiento de insuficiencia cardiaca cronica. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040122067A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1581308A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006514051A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2506719A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05006628A (cg-RX-API-DMAC7.html) |
| PL (1) | PL375893A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004060489A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005027887A2 (en) * | 2003-09-17 | 2005-03-31 | Cardimone Pharma Corporation | Methods and compositions for improving endothelial function |
| WO2006121995A2 (en) * | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| CA2669935A1 (en) * | 2006-11-13 | 2008-05-29 | Takeda Pharmaceuticals North America, Inc. | Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| RU2009131454A (ru) * | 2007-01-19 | 2011-02-27 | Такеда Фармасьютикалз Норт Америка, Инк. (Us) | Способы предупреждения или уменьшения числа обострений подагры с применением ингибиторов ксантиноксидоредуктазы и противовоспалительных средств |
| US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
| GB0909243D0 (en) * | 2009-05-29 | 2009-07-15 | Univ Dundee | Angina treatment |
| IT1400309B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
| IT1400609B1 (it) | 2010-05-10 | 2013-06-14 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
| IT1400311B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
| IT1400310B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e statine e loro uso. |
| JP5978216B2 (ja) | 2010-09-10 | 2016-08-24 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | テオフィリンとフェブキソスタットの併用療法のための方法 |
| US20170217948A1 (en) | 2014-07-30 | 2017-08-03 | Teijin Pharma Limited | Xanthine oxidase inhibitor |
| JP6684264B2 (ja) * | 2015-02-17 | 2020-04-22 | 株式会社三和化学研究所 | 心不全の予防又は治療のための医薬 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2073981C (en) * | 1990-11-30 | 2002-01-08 | Shiro Kondo | 2-arylthiazole derivatives and pharmaceutical composition thereof |
| AU1520699A (en) * | 1997-11-07 | 1999-05-31 | Johns Hopkins University, The | Methods for treatment of disorders of cardiac contractility |
| CZ297264B6 (cs) * | 1998-09-09 | 2006-10-11 | Metabasis Therapeutics, Inc. | Nové heteroaromatické inhibitory fruktóza-1,6-bisfosfatázy |
| DE69942009D1 (de) * | 1998-10-15 | 2010-03-25 | Imp Innovations Ltd | Verbindungen für die behandlung von gewichtsverlust |
| EP1212064A2 (en) * | 1999-03-09 | 2002-06-12 | Max-Delbrück-Centrum Für Molekulare Medizin | Use of inhibitors of endotoxin for the treatment of heart failure and of cachexia |
-
2002
- 2002-12-20 US US10/325,420 patent/US20040122067A1/en not_active Abandoned
-
2003
- 2003-12-11 CA CA002506719A patent/CA2506719A1/en not_active Abandoned
- 2003-12-11 EP EP03796950A patent/EP1581308A2/en not_active Withdrawn
- 2003-12-11 JP JP2004565376A patent/JP2006514051A/ja active Pending
- 2003-12-11 MX MXPA05006628A patent/MXPA05006628A/es unknown
- 2003-12-11 PL PL03375893A patent/PL375893A1/xx unknown
- 2003-12-11 WO PCT/US2003/039410 patent/WO2004060489A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004060489A3 (en) | 2004-11-25 |
| JP2006514051A (ja) | 2006-04-27 |
| EP1581308A2 (en) | 2005-10-05 |
| CA2506719A1 (en) | 2004-07-22 |
| PL375893A1 (en) | 2005-12-12 |
| WO2004060489A2 (en) | 2004-07-22 |
| US20040122067A1 (en) | 2004-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004060489A3 (en) | Treatment of chronic heart failure | |
| WO2003079979A3 (en) | Method for treating congestive heart failure | |
| BR0212252A (pt) | Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero | |
| EA200500859A1 (ru) | Хинолинилпирролопиразолы | |
| NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
| EA200200767A1 (ru) | Лечение застойной сердечной недостаточности предварительно обработанной аутологичной кровью | |
| MXPA02007639A (es) | Inhibidores de la oxidacion parcial de los acidos grasos en el tratamiento de la falla cardiaca congestiva. | |
| BRPI0415395A (pt) | composto, métodos para inibir a atividade da proteìna quinase e para tratar um paciente que tenha uma condição que seja mediada pela atividade da proteìna quinase, e, composição | |
| GB0328548D0 (en) | Treatment of pain | |
| SI1551409T1 (sl) | Uporaba kinazolinskega derivata ZD6474, kombiniranega z gemcitabinom in po želji ionizirajočim obsevanjem, pri zdravljenju raka | |
| NO20050204L (no) | Kombinasjoner av legemidler for behandling av neoplasmer | |
| WO2005049084A3 (en) | Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure | |
| DE602004022287D1 (de) | Vielzahl an therapie-modalitäten | |
| EA200200324A1 (ru) | Способы применения селективных ингибиторов обратного захвата серотонина быстрого запуска для лечения половой дисфункции | |
| IL169702A0 (en) | Combination therapy of zd6474 with 5-fu or/and cpt-11 | |
| WO2005062958A3 (en) | Meth0ds of using hcn genes to treat cardiac arrhythmias | |
| PL1732551T3 (pl) | Perheksylina do leczenia przewlekłej niewydolności serca | |
| WO2022081610A8 (en) | TREATMENT OF COGNITIVE IMPAIRMENT WITH A CNS-PENETRANT sGC STIMULATOR | |
| TR200003194T2 (tr) | Hastalık tedavisine mahsus sPLA2 önleyici bileşikler | |
| WO2003022882A3 (en) | Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle | |
| IL159770A0 (en) | Calcium salts with cytotoxic activity | |
| NO20024545L (no) | Fremgangsmåte for behandling av kongestiv hjertefeil | |
| TW200514582A (en) | Transdermal preparation and method for reducing side effect in pergolide therapy | |
| EA200400817A1 (ru) | Идрапаринукс для лечения и вторичной профилактики случаев венозной тромбоэмболии у пациентов с тромбозом глубоких вен | |
| WO2005102367A3 (en) | Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer |